Biopôle Clermont-Limagne
Technology park for life sciences
Year of creation : 2002
Statut : simplified joint stock company
Size : 1
% of CA dedicated to R&D : 100 %
Patents (number of) : 4

Contact details

Biopôle Clermont-Limagne
5 rue Emile Duclaux
63360 Saint-Beauzire

Contact : François Boutignon
Phone : +33 473 670 670
Email :
Website :

Aptys Pharmaceuticals

Formulation, analytical development and validation, quality control, stability studies

APTYS PHARMACEUTICALS is a spin-off of the University of Clermont-Ferrand, (France). It was founded in 2002 and took over formulation patents from the University involving various types of drug delivery technologies. Since then, the company developed products for clients and also for internal projects with the objective of out-licensing them to pharmaceutical firms. 


Up to 2018, several technologies were licensed out such as bioadhesive tablets, microspheres, creams, and several products are now either on the market or under development, namely Loramyc© and Testocream©.


In 2013, APTYS PHARMACEUTICALS has started in the frame of the cluster Analgesia Partnership, the development of Metapain, a new product for the treatment of moderate to severe pain.


In 2017, APTYS PHARMACEUTICALS signed an agreement with UNITHER PHARMACEUTICALS to co-develop Metapain


In 2018, APTYS PHARMACEUTICALS decided to split activities into two branches with one dedicated to the development of Metapain and another taking care of service operations.